ResourceLife Sciences
Generation and characterization of diverse modality ADCs
10 Nov 2025Explore ChemPartner’s research on next-generation antibody-drug conjugates (ADCs), including monospecific, bispecific, biparatopic, dual-payload, and trispecific modalities. See how multispecific designs improve internalization, cytotoxicity, and therapeutic efficacy, addressing tumor heterogeneity and drug resistance in cancer therapy.
Links
Tags
AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Antibody Drug ConjugatesCancer ResearchCancer research aims to understand the mechanisms of cancer development and progression to improve prevention, diagnosis, and treatment. From molecular biology to clinical trials, research spans a wide range of disciplines, including immunotherapy, targeted therapies, and drug discovery. Explore the best cancer research products in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.